Avidity Biosciences, Inc. — Director's Dealing 2021

Jan 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2021-01-11

Reporting Person: Kim Jean Jinsun (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-11	Stock Option (Right to Buy)	$27.63	A	30000	Acquired	2031-01-10	Common Stock (30000)	Direct

Footnotes

F1: The option was granted on January 11, 2021 and shall vest in substantially equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.